Alzheimer’s, Dementia and Parkinson's Research
Statistics from the Alzheimer’s Society state that someone develops dementia in the UK every three minutes. Dementia and Alzheimer’s disease are now the leading causes of death in the UK.
What causes Alzheimer's, Dementia or Parkinson's?
The human brain is made up of billions of nerve cells, all of which are interconnected. When someone develops Alzheimer’s disease, barriers (made up of a collection of proteins - called “plaques”) start to spring up between the nerve cells so they no longer communicate to each other.
Over time these nerve cells degenerate and die, decreasing the amount of brain tissue that the person suffering with Alzheimer’s has. In addition to the barriers within the brain, people with Alzheimer’s also have less of the important chemicals that send messages around the brain, making these signals weaker.
There is no cure for Alzheimer’s, Dementia or Parkinson’s (ADP).
Current treatment options to slow down the symptoms for people suffering from ADP range from drugs that help to boost the chemicals in the brain that pass on messages, to alternative therapies and counselling that help people to come to terms with the condition and its implications.
There is a real need to find a cure for this life-changing and life-limiting condition.
What NTU is doing
At Nottingham Trent University we have a unique opportunity to create a multi-disciplinary team of experts to explore new and innovative methods to bring about change in the prognosis of these destructive diseases.
One of the strengths of NTU’s research is that we work collaboratively to explore problems. This multi-disciplinary approach means that different perspectives and specialisms can bring about novel solutions.
This research collaboration brings together chemical engineers, nano-scientists and hydrogen production specialists, to name a few. Research by Dr Gareth Cave and his team will use ultrasound, ultraviolet light, radio frequency and nano bubbles of hydrogen to break down the barriers that are inhibiting the treatment of ADP.
What you can do
In order to develop new solutions, our team combines their knowledge to pioneer new approaches in the prevention and treatment of ADP.
This work has been made possible to date by the generosity of Professor Tony Marmont’s personal philanthropy, in memory of his wife Angela Marmont.
Please join us on this journey and be part of something life-changing.
Our alumni and supporters’ enable amazing things to happen at Nottingham Trent University. Contact the Development and Alumni Relations Team on email@example.com or telephone +44 (0)115 848 8777.